These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11320368)

  • 1. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.
    Anker SD; Doehner W; Rauchhaus M; Sharma R; Francis D; Knosalla C; Davos CH; Cicoira M; Shamim W; Kemp M; Segal R; Osterziel KJ; Leyva F; Hetzer R; Ponikowski P; Coats AJ
    Circulation; 2003 Apr; 107(15):1991-7. PubMed ID: 12707250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow.
    Doehner W; Bunck AC; Rauchhaus M; von Haehling S; Brunkhorst FM; Cicoira M; Tschope C; Ponikowski P; Claus RA; Anker SD
    Eur Heart J; 2007 Apr; 28(7):821-8. PubMed ID: 17353227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure.
    Jankowska EA; Ponikowska B; Majda J; Zymlinski R; Trzaska M; Reczuch K; Borodulin-Nadzieja L; Banasiak W; Ponikowski P
    Int J Cardiol; 2007 Feb; 115(2):151-5. PubMed ID: 16782216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricemia associated with high cardiac event rates in the elderly with chronic heart failure.
    Niizeki T; Takeishi Y; Arimoto T; Okuyama H; Nozaki N; Hirono O; Tsunoda Y; Watanabe T; Nitobe J; Miyashita T; Takahashi H; Koyama Y; Kubota I
    J Cardiol; 2006 May; 47(5):219-28. PubMed ID: 16764328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure.
    Siednienko J; Jankowska EA; Banasiak W; Gorczyca WA; Ponikowski P
    Int J Cardiol; 2007 Nov; 122(2):111-6. PubMed ID: 17270295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial measurements of peripheral vascular reactivity and exercise capacity in congestive heart failure and after heart transplantation.
    Hognestad A; Holm T; Simonsen S; Kjekshus J; Andreassen AK
    J Card Fail; 2005 Aug; 11(6):447-54. PubMed ID: 16105636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
    Doehner W; Schoene N; Rauchhaus M; Leyva-Leon F; Pavitt DV; Reaveley DA; Schuler G; Coats AJ; Anker SD; Hambrecht R
    Circulation; 2002 Jun; 105(22):2619-24. PubMed ID: 12045167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
    von Haehling S; Schefold JC; Jankowska EA; Springer J; Vazir A; Kalra PR; Sandek A; Fauler G; Stojakovic T; Trauner M; Ponikowski P; Volk HD; Doehner W; Coats AJ; Poole-Wilson PA; Anker SD
    J Am Coll Cardiol; 2012 Feb; 59(6):585-92. PubMed ID: 22300693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are hematinic deficiencies the cause of anemia in chronic heart failure?
    Witte KK; Desilva R; Chattopadhyay S; Ghosh J; Cleland JG; Clark AL
    Am Heart J; 2004 May; 147(5):924-30. PubMed ID: 15131553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blunted local but preserved remote vascular responses after resistance exercise in chronic heart failure.
    Guindani G; Umpierre D; Grigoletti SS; Vaz M; Stein R; Ribeiro JP
    Eur J Prev Cardiol; 2012 Oct; 19(5):972-82. PubMed ID: 21813573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inspiratory muscle training improves blood flow to resting and exercising limbs in patients with chronic heart failure.
    Chiappa GR; Roseguini BT; Vieira PJ; Alves CN; Tavares A; Winkelmann ER; Ferlin EL; Stein R; Ribeiro JP
    J Am Coll Cardiol; 2008 Apr; 51(17):1663-71. PubMed ID: 18436118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry.
    Baldasseroni S; Urso R; Maggioni AP; Orso F; Fabbri G; Marchionni N; Tavazzi L;
    Nutr Metab Cardiovasc Dis; 2012 May; 22(5):442-8. PubMed ID: 21193292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
    Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
    Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible nitric oxide synthase activity does not contribute to the maintenance of peripheral vascular tone in patients with heart failure.
    Dover AR; Chia S; Ferguson JW; Cruden NL; Megson IL; Fox KA; Newby DE
    Clin Sci (Lond); 2006 Oct; 111(4):275-80. PubMed ID: 16803456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival.
    Genth-Zotz S; Bolger AP; Kalra PR; von Haehling S; Doehner W; Coats AJ; Volk HD; Anker SD
    Int J Cardiol; 2004 Sep; 96(3):397-401. PubMed ID: 15301893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
    van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.